Efexor XL licence extended

Efexor XL (venlafaxine) is now indicated in moderate to severe generalised social anxiety disorder/social phobia in adults.

Efexor is also indicated in major depressive disorder and in moderate to severe generalised anxiety disorder. The recommended dose in social anxiety disorder is 75mg once daily.

If the patient has failed to respond after 12 weeks, alternative therapy should be considered. Continuation of treatment in a responding patient can be considered on an individual basis, but there is no evidence of efficacy beyond six months.

 

Further information: Wyeth 0845 3670098

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Prescribers warned over topical steroid withdrawal reactions

Prescribers warned over topical steroid withdrawal reactions

The MHRA has issued advice for prescribers to minimise...

New products - live tracker

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Products coming soon - live tracker

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...